deltatrials
Completed NA INTERVENTIONAL 1-arm NCT03139435

Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer

A Pilot Study Using Ultrasound for the Detection of Taxane-Induced Peripheral Neuropathy

Sponsor: National Cancer Institute (NCI)

Conditions Peripheral Neuropathy Stage 0 Breast Cancer Stage I Breast Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage III Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer
Interventions Biopsy Questionnaire Administration Ultrasound Tomography
Updated 17 times since 2017 Last updated: Apr 4, 2024 Started: May 11, 2017 Primary completion: Dec 12, 2018 Completion: Jan 11, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Peripheral Neuropathy and Stage 0 Breast Cancer, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 17 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Dec 2018 · 4 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~May 2019 · 4 months · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Jan 2020 · 2 months · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Jun 2020 · 4 months · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshot~Jan 2021 – ~May 2024 · 40 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 21 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. May 2024 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2021 — May 2024 [monthly]

    Completed NA

  5. Jun 2020 — Jan 2021 [monthly]

    Completed NA

▶ Show 12 earlier versions

  1. Feb 2020 — Jun 2020 [monthly]

    Completed NA

  2. Jan 2020 — Feb 2020 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  3. Nov 2019 — Jan 2020 [monthly]

    Active Not Recruiting NA

  4. Oct 2019 — Nov 2019 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  5. Sep 2019 — Oct 2019 [monthly]

    Recruiting NA

  6. Jun 2019 — Sep 2019 [monthly]

    Recruiting NA

  7. May 2019 — Jun 2019 [monthly]

    Recruiting NA

  8. Jan 2019 — May 2019 [monthly]

    Recruiting NA

  9. Dec 2018 — Jan 2019 [monthly]

    Recruiting NA

  10. Aug 2018 — Dec 2018 [monthly]

    Recruiting NA

  11. Jun 2018 — Aug 2018 [monthly]

    Recruiting NA

  12. Jun 2017 — Jun 2018 [monthly]

    Recruiting NA

    First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • Wake Forest University Health Sciences
Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations